Prof Robyn Guymer to head up new 2RT study for iAMD
Adelaide-based Nova Eye Medical says it has navigated a time-consuming and complex series of conversations with the US Food and ...
Adelaide-based Nova Eye Medical says it has navigated a time-consuming and complex series of conversations with the US Food and ...
US regulators have approved the country’s first presbyopia eye drop that adopts pupil constriction to improve near and intermediate vision ...
Glaukos has signed a new license agreement with Santen Pharmaceutical for the Preserflo MicroShunt, obtaining exclusive rights for the therapy ...
Nova Eye Medical has announced eight surgery centres across the US have commenced a prospective, randomised clinical trial to assess ...
A US Food and Drug Administration (FDA) policy that automatically disqualifies men who have had sex with men in the ...
Horizon Therapeutics has had its drug Tepezza, which is the first ever treatment for thyroid eye disease, approved by The ...
CooperVision has received clearance from the US Food and Drug Administration (FDA) for its MiSight 1 Day Contact Lens for ...
Novartis has secured US regulatory approval for Beovu, the company’s latest therapy for neovascular age-related macular degeneration (nAMD), following the ...
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited